🇺🇸 FDA

Company profile · Sponsor

Essential

Essential Pharma Limited

SNTI · NYSE pharma SOUTH SAN FRANCISCO, CA, GB
Pipeline
2
Drugs
3
Patents
8

Quick answer

Essential (SNTI) is a pharma company. headquartered in SOUTH SAN FRANCISCO, CA, GB. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 3 drugs, and 8 patents to this profile..

Company facts

Ticker SNTI
Exchange NYSE
Company type pharma
Headquarters SOUTH SAN FRANCISCO, CA, GB
SEC CIK 0001854270

Pipeline (2)

Search pipeline →

  1. SENTI-202

    Essential

    AML/MDS

    phase 1 mab active

    1 trial

  2. SN301A

    Essential

    Hepatocellular Carcinoma (HCC)

    phase 1 mab active

    1 trial

Drugs (3)

Search drugs →

  1. colistimethate sodium

    COLOBREATHE

    INJECTION approved

    J01XB01

  2. ketotifen fumarate

    KETOTIFEN FUMARATE

    OPHTHALMIC approved

  3. ropeginterferon alfa-2b-njft

    BESREMI

    SUBCUTANEOUS approved

Patents (8)

Search patents →

  1. US 12419895

    Methods for treating subjects with Prader-Willi syndrome

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12350258

    Compositions and methods for treatment of skin-related diseases and promoting dermatological health

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12343348

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12343381

    Dosage regimen for pegylated interferon

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12178823

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12109216

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12005081

    Chimeric receptors and methods of use thereof

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11884656

    Pyrrole derivatives as PLK1 inhibitors

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Essential?

Essential (SNTI) is a pharma company. headquartered in SOUTH SAN FRANCISCO, CA, GB. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 3 drugs, and 8 patents to this profile..

What pipeline programs does Essential sponsor?

We track 2 ClinicalTrials.gov-linked programs for Essential, including SENTI-202 and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Essential company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.